Bibliographic Details
| Title: |
Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation. |
| Authors: |
Nobutaka Nakamura, Takanori Matsui, Yuji Ishibashi, Sho-ichi Yamagishi |
| Source: |
Diabetology & Metabolic Syndrome; 2015, Vol. 7 Issue 1, p1-6, 6p, 3 Graphs |
| Subject Terms: |
SODIUM-glucose cotransporters, OXIDATIVE stress, INSULIN, DIABETIC nephropathies, PEOPLE with diabetes, THERAPEUTICS |
| Abstract: |
Background: Ninety percent of glucose filtered by the glomerulus is reabsorbed by a sodium-glucose cotransporter 2 (SGLT2), which is expressed mainly on the apical membrane of renal proximal tubules. Since SGLT-2-mediated glucose reabsorption is enhanced under diabetic conditions, selective inhibition of SGLT2 has been proposed as a potential therapeutic target for the treatment of patients with diabetes. However, it remains unclear which diabetes-associated factors are involved in overexpression of SGLT2. Methods: Therefore, in this study, we examined whether insulin, high glucose, advanced glycation end products (AGEs), or H2O2 stimulated SGLT2 expression in human cultured proximal tubular cells, and then investigated the underlying molecular mechanisms. Results: High glucose or AGEs did not affect SGLT2 expression in tubular cells. Insulin significantly increased tubular SGLT2 level in a dose-dependent manner, whereas bell-shaped dose-response curves were observed for H2O2-treated cells. An anti-oxidant, N-acetylcysteine completely blocked insulin-induced up-regulation of SGLT2 as well as increase in glucose absorption by tubular cells. Furthermore, insulin dose-dependently increased reactive oxygen species generation in tubular cells. Conclusions: Our present study demonstrated that insulin could stimulate SGLT-2-mediated glucose entry into cultured proximal tubular cells via oxidative stress generation. Suppression of the insulin-induced overexpression of SGLT2 in tubular cells might be a novel therapeutic strategy for the treatment of diabetic nephropathy. [ABSTRACT FROM AUTHOR] |
|
Copyright of Diabetology & Metabolic Syndrome is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
